weight regain tirzepatide Rebound Gain After Stopping (Mounjaro or Zepbound) Tirzepatide withdrawal leads to 25%

When to avoid injecting in the thigh The thigh is excellent for most people most of the time

After 36 weeks of open-label tirzepatide treatment producing an average 20.9 percent weight loss, participants were randomized to either continue tirzepatide or switch to placebo

Normal glycemic levels, defined as having an HbA1c of less than 5.7%, were achieved by 46% of adults in the 10 mg tirzepatide group and 48.6% of the 15 mg tirzepatide group compared with 3.9% of those receiving placebo

[53] Treatment was given for 40 weeks

How retatrutide and tirzepatide work differently Before comparing dosages, you need to understand why these two compounds require different dosing strategies in the first place

That said, clinical experience has produced some rough approximations that providers use when switching patients